-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

904A.O1.6 904. Outcomes Research—Malignant Conditions: Outcomes in Myeloid Malignancies and Allogeneic Stem Cell Transplant

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, AML, Diseases, Adult, survivorship, bone marrow, Therapies, Elderly, MDS, Study Population, Clinically relevant, Myeloid Malignancies, transplantation, stem cells
Sunday, December 2, 2018: 9:30 AM-11:00 AM
Room 25B (San Diego Convention Center)
Moderators:
Nandita Khera, MD, Mayo Clinic and Lori S Muffly, MD, Stanford University
Disclosures:
Muffly: Shire Pharmaceuticals: Research Funding; Adaptive Biotechnologies: Research Funding.
9:30 AM

Jesus Garcia Garcia, BS1*, Sonya Grillo2*, Qing Cao, MS3*, Claudio G Brunstein, MD, PhD4, Mukta Arora, MD5, Margaret L. MacMillan, MD6, John E. Wagner, MD7, Daniel J. Weisdorf, MD8 and Shernan G. Holtan, MD8

1University of Minnesota, Minneapolis, MN
2University of Minnesota, Minneapolis
3Department of Biostatistics & Bioinformatics, University of Minnesota, Minneapolis, MN
4Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN
5Division of Hematology, Oncology and Transplantation,, University of Minnesota, Minneapolis, MN
6Division of Pediatric Blood and Marrow Transplantation, University Of Minnesota, Minneapolis, MN
7Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
8Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

9:45 AM

F. Lennie Wong, PhD1*, Meisi Xiao, MPH1*, Jennifer Berano Teh1*, Liezl Atencio1*, Alicia Gonzales1*, Amy Hinton1*, David Iukuridze1*, Stephen J Forman2,3, Ryotaro Nakamura, MD3,4 and Saro H. Armenian, DO, MPH1

1Department of Population Sciences, City of Hope, Duarte, CA
2Department of Hematology/HCT, City of Hope, Duarte, CA
3Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
4Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute., City of Hope Nat'l Med. Ctr., Duarte, CA

10:00 AM

Lena Winestone, MD1,2, Kelly D Getz, PhD1*, Yimei Li, PhD1*, Evanette Burrows, MPH3*, Michael Scheurer, MPH, PhD4*, M. Monica Gramatges, MD, PhD5, Jennifer J. Wilkes, MD6, Tamara P. Miller, MD, MSc7, Alix E. Seif, MD1, Robert W. Grundmeier, MD3*, Karen R. Rabin, MD, PhD8, Brian T. Fisher, DO9* and Richard Aplenc, MD, PhD1

1Center for Childhood Cancer Research, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Division of Allergy, Immunology, and BMT, UCSF Benioff Children's Hospital, San Francisco, CA
3Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
4Division of Hematology-Oncology, Texas Children's Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX
5Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX
6Department of Pediatrics, University of Washington, Division of Hematology/Oncology, Seattle Children’s Hospital, Seattle, WA
7Children’s Healthcare of Atlanta, Emory University, Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Atlanta, GA
8Division of Hematology-Oncology, Texas Children’s Hospital, Department of Pediatrics, Baylor College of Medicine, Houston, TX
9Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, PA

10:15 AM

Amer M. Zeidan, MBBS, MHS1,2, Xin Hu, MS3*, Weiwei Zhu, MPH3*, Maximilian Stahl, MD1,3, Smith Giri, MBBS4,5, Scott F Huntington, MD, MPH5,6, Rong Wang, PhD5,7*, Nikolai A. Podoltsev, MD, PhD1,3, Steven D. Gore, MD1,5, Xiaomei Ma, MD, PhD3,7* and Amy J. Davidoff, PhD, MS5,8*

1Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT
2Yale Cancer Center, New Haven, CT
3Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT
4Section of Hematology, Yale University School of Medicine, New Haven, CT
5Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT
6Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
7Department of Chronic Diseases, Yale School of Public Health, Yale University, New Haven, CT
8Department of Health Policy and Management, Yale University School of Public Health, New Haven, CT

10:30 AM

Raffi Tchekmedyian, BS1, Tomas Radivoyevitch, PhD2*, Aaron T. Gerds, MD, MS3, Aziz Nazha, MD4, Hetty E. Carraway, MD, MBA5,6,7, Anjali S. Advani, MD6, Jaroslaw P. Maciejewski2, Matt Kalaycio, MD8, Navneet S. Majhail, MD, MS8, Mikkael A. Sekeres, MD, MS9 and Sudipto Mukherjee, MD, PhD, MPH9

1Cleveland Clinic Foundation, Cleveland, OH
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
3Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
4Cleveland Clinic, Avon Lake, OH
5Taussig Cancer Institute, Cleveland Clinic, Department of Hematology and Medical Oncology, Cleveland, OH
6Taussig Cancer Institute, Cleveland Clinic, Leukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH
7Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
8Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
9Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

10:45 AM

Robert K. Hills, MA, DPhil, MSc1, Ian Thomas2*, Alan K. Burnett, MD3, Claire Jane Hemmaway, MD4*, Helen Dignum5*, Nigel H. Russell6 and Michael Dennis, MD, MRCP, FRCPath7

1Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Welsh School of Medicine, Cardiff, WAL, United Kingdom
2Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
3Blackwaterfoot, Isle of Arran, United Kingdom
4BHRUT, Romford, GBR
5Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom
6Nottingham University Hospital, Nottingham, United Kingdom
7Department of Haematology and Transplant, The Christie, Manchester, United Kingdom

*signifies non-member of ASH